Kearney, Niamh http://orcid.org/0000-0002-6469-3462
Kirby, Brian http://orcid.org/0000-0001-7596-892X
Funding for this research was provided by:
The City of Dublin Skin and Cancer Hospital Charity
University College Dublin
Article History
Accepted: 16 July 2022
First Online: 23 August 2022
Declarations
:
: Open Access funding provided by the IReL Consortium. N.K. is in receipt of grant funding from the City of Dublin Skin and Cancer Hospital Charity.
: N.K. has received honoraria from AbbVie, Janssen and UCB and has acted as a sub-investigator in clinical trials for AbbVie and UCB. B.K. has received research support/principal investigator (clinical trials) from AbbVie, Almirall, Janssen, Merck Sharpe Dohme, MoonLake, Novartis, Pfizer and UCB; been a consultant for AbbVie, Almirall, Celgene, Janssen, Merck Sharpe Dohme, MoonLake, Novartis, Pfizer and UCB; received honoraria from AbbVie, Almirall, Celgene, Janssen, Lilly, MoonLake, Novartis, Pfizer and UCB; and been on scientific advisory boards for AbbVie, Almirall, Celgene, Janssen, Lilly, MoonLake, Novartis, Pfizer and UCB.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.